CN Patent

CN105209018B — 劳拉西泮的缓释制剂

Assigned to EDGEMONT PHARMACEUTICALS LLC · Expires 2019-06-25 · 7y expired

What this patent protects

用延长释放劳拉西泮药物珠子实现了用于以延长方式递送劳拉西泮的药物组合物。所述组合物通常含有缓释劳拉西泮珠子和延迟缓释劳拉西泮珠子。所述组合物可以提供每天1次施用，其在稳态条件下维持24小时治疗效果。

USPTO Abstract

用延长释放劳拉西泮药物珠子实现了用于以延长方式递送劳拉西泮的药物组合物。所述组合物通常含有缓释劳拉西泮珠子和延迟缓释劳拉西泮珠子。所述组合物可以提供每天1次施用，其在稳态条件下维持24小时治疗效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN105209018B
Jurisdiction
CN
Classification
—
Expires
2019-06-25
Drug substance claim
No
Drug product claim
No
Assignee
EDGEMONT PHARMACEUTICALS LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.